Post-Surgical Opioid Use in a 16-Year-Old: Level of Care and Differential
Jordan is a 16-year-old high school sophomore who underwent ACL reconstruction eight weeks ago. She was prescribed oxycodone 5 mg every six hours and now reports taking 40–50 mg daily. She has obtained additional tablets from a friend and has used intranasally twice. A urine drug screen is positive for fentanyl and oxycodone; she denies injection or heroin use. She reports yawning, runny nose, gooseflesh, anxiety, and insomnia since her prescription ran out two days ago. She has a history of generalized anxiety disorder diagnosed at 14 and sees a therapist monthly. Her parents believe she is taking medication as prescribed. Jordan says she wants to stop but is afraid of withdrawal. She is medically stable, afebrile, with normal vital signs except pulse 98 and blood pressure 128/78.
1. Apply the ASAM criteria to determine the appropriate level of care for withdrawal management and justify your recommendation.
Read the worked answer
ASAM Dimension 1 (withdrawal) is the driver. Jordan has objective opioid withdrawal signs-rhinorrhea, yawning, piloerection, insomnia, anxiety-and a pulse of 98. Her use is intranasal, her supply is uncertain, and the urine shows fentanyl, which carries high overdose risk. She is medically stable, afebrile, and not vomiting or confused.
ASAM Level 2-WM (ambulatory withdrawal management) could be appropriate only if a responsible adult can monitor her daily, she can attend daily visits, and there is a plan for buprenorphine initiation and naloxone. However, because she is 16, has concealed use from parents, has fentanyl exposure, and has a co-occurring anxiety disorder, Level 3.7-WM (medically monitored intensive inpatient withdrawal management) is the safer recommendation until she is stabilized and the family system is engaged. Level 1 is too low because of fentanyl and daily dosing. Justify with Dimensions 2–6: no severe medical instability, but high relapse risk and environmental access to pills. Reassess after 72 hours.
2. What diagnostic considerations should guide your differentiation between opioid use disorder, opioid-induced anxiety, and her pre-existing generalized anxiety disorder?
Read the worked answer
Distinguish by timeline and context. Opioid use disorder is supported by tolerance, taking more than prescribed, obtaining extra opioids, intranasal use, continued use despite consequences, and withdrawal. Opioid-induced anxiety disorder would be diagnosed if anxiety symptoms are attributable to intoxication or withdrawal and remit with abstinence; her anxiety since the prescription ran out is likely withdrawal-related.
Her pre-existing GAD diagnosed at 14 must not be assumed to explain all current symptoms. GAD can be diagnosed independently if anxiety predates opioid use, persists beyond withdrawal, and is not better explained by it. The key is to reassess after two to four weeks of abstinence and stabilization. Do not stop her anxiety treatment abruptly. Use a unified treatment plan addressing both, with CBT for anxiety and medication evaluation. Document the differential.